Cargando…
DEK promoted EMT and angiogenesis through regulating PI3K/AKT/mTOR pathway in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer associated with poor prognosis. As an oncogene, DEK involves in regulation of various cellular metabolisms and plays an important role in tumor growth and progression. Increasing evidences suggested that abnormal ex...
Autores principales: | Yang, Yang, Gao, Meihua, Lin, Zhenhua, Chen, Liyan, Jin, Yu, Zhu, Guang, Wang, Yixuan, Jin, Tiefeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716761/ https://www.ncbi.nlm.nih.gov/pubmed/29228721 http://dx.doi.org/10.18632/oncotarget.21864 |
Ejemplares similares
-
PI3K/AKT/mTOR Pathway in Angiogenesis
por: Karar, Jayashree, et al.
Publicado: (2011) -
NQO1 drives glioblastoma cell aggressiveness through EMT induction via the PI3K/Akt/mTOR/Snail pathway
por: Zheng, Lan, et al.
Publicado: (2023) -
PI3K/mTOR dual inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A synergistically exert anti-tumor activity in breast cancer
por: Chen, Liyan, et al.
Publicado: (2017) -
Superior efficacy of co-treatment with the dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A against NSCLC
por: Piao, Junjie, et al.
Publicado: (2016) -
Mechanisms Underlying Cancer Growth and Apoptosis by DEK Overexpression in Colorectal Cancer
por: Lin, Lijuan, et al.
Publicado: (2014)